Guinea-Bissau approves controversial hepatitis B vaccine trial backed by Robert F. Kennedy Jr.
A research trial that will withhold hepatitis B vaccines from some African newborns has been approved to move forward in Guinea-Bissau, with the CDC reportedly allocating $1.6 million for the study. The trial is central to Robert F. Kennedy Jr.'s vaccine agenda and has drawn widespread criticism as unethical.
